Five individually attributed targets were reviewed for this stock price target calculation. Canaccord Genuity initiated coverage with a Buy and a $25 target, Cantor Fitzgerald with a Speculative Buy and $34, B. Riley Securities with a Buy and $28, and Stifel with a Buy and $30 — all around early June 2026. Jefferies later initiated coverage with a Hold and a $12 target in early September 2026.
The arithmetic mean of these five figures is roughly $25.80, which rounds to a $26 central target. The low-to-high range of $12 to $34 is unusually wide, a direct result of the company being pre-revenue and at the exploration stage. Bullish analysts emphasize Rare Earths Americas' lower-cost ion-adsorption clay processing and its inferred resource base rich in heavy rare earths such as dysprosium and terbium. The more cautious Jefferies view highlights that the company remains a pre-revenue, exploration-stage business with meaningful development risk. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As of mid-November 2026, REA traded near $5.62, toward the bottom of its 52-week range of roughly $5.26 to $30.02. The stock priced its IPO at $19 per share in May 2026, meaning it has lost roughly 70% since listing. Reaching the $26 central target from $5.62 implies a gain of approximately 363%, a very large move that would require the shares to more than quadruple.
There is no near-term earnings catalyst in the traditional sense, because the company generates no revenue and reports losses — EPS (earnings per share) was negative over the trailing twelve months, and the business is funding exploration and development with cash. The path toward a higher valuation therefore runs through project milestones, such as expanded resource estimates and early economic studies, rather than quarterly profit growth.
The core thesis is geopolitical. Western governments and manufacturers are working to reduce dependence on China for rare earth elements, and REA positions itself as a future supplier of heavy rare earths — including dysprosium and terbium — that are critical to high-performance permanent magnets used in robotics, defense, electric vehicles, wind power and consumer electronics. Its portfolio pairs a U.S. asset (the Shiloh Project in Georgia) with high-grade Brazilian ionic clay projects, and analysts cite ion-adsorption clay processing as commercially validated and lower-cost than hard-rock alternatives. A continued policy push for non-Chinese supply chains, rising rare earth prices, or successful resource upgrades could all support sentiment.
The principal obstacle is that REA is an exploration-stage company with no revenue. Advancing projects requires substantial additional capital, creating the risk of equity dilution, and there is no guarantee that resources translate into economically viable mines. Rare earth prices are volatile and remain influenced by China, which dominates global supply. A pullback in critical minerals enthusiasm, delays in permitting or feasibility work, or a broader risk-off move in speculative small-cap mining stocks could all keep the shares depressed. The fact that the stock sits near its 52-week low shows how quickly sentiment toward the sector can deteriorate.
REA is trading near its post-IPO low, with the 52-week low around $5.26 acting as nearby support and the $5.00 level serving as a psychological floor. The $19 IPO offer price marks a meaningful overhead zone, and the 52-week high near $30 sits just above the highest analyst target. Given how far the stock has fallen, the chart offers little near-term evidence of a sustained uptrend; a durable recovery would first need to reclaim levels well above the current price.
Analyst price targets typically reflect a roughly 12-month research horizon, and these initiation targets were set between June and September 2026. Investors should watch for exploration and development updates — particularly expanded resource estimates and any preliminary economic assessment for the Shiloh, Alpha and Constellation projects — along with financing announcements, rare earth price trends, and U.S. critical minerals policy developments. Quarterly updates on cash position and spending are also important given the pre-revenue status. None of this provides a basis for a definitive forecast.
For traders who prefer a systematic approach to timing, I find Tickeron's AI Daily Buy/Sell Signals helpful. This tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell or Hold signals based on changing market conditions, technical behavior and AI-driven analysis. It can help identify opportunities, keep an eye on existing positions and flag shifting trends more efficiently than manual scanning. Investors considering REA — or any other holding — may find it a useful complement to fundamental research.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator entered the oversold zone -- be on the watch for REA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a +10.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where REA advanced for three days, in 16 of 19 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
REA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on REA as a result. In 5 of 6 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence Histogram (MACD) for REA turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 4 similar instances when the indicator turned negative. In 3 of the 4 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where REA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for REA entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.892) is normal, around the industry mean (6.813). P/E Ratio (-4.167) is within average values for comparable stocks, (-0.701). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.026). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (283.864).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. REA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OtherMetalsMinerals